View Item 

Show simple item record

Clinical and Serologic Markers of Periodontal Infection and Chronic Kidney Disease
dc.contributor.authorFisher, Monica A.
dc.contributor.authorTaylor, George W.
dc.contributor.authorPapapanou, Panos N.
dc.contributor.authorRahman, Mahboob
dc.contributor.authorDebanne, Sara M.
dc.date.accessioned2018-02-05T16:34:38Z
dc.date.available2018-02-05T16:34:38Z
dc.date.issued2008-09
dc.identifier.citationFisher, Monica A.; Taylor, George W.; Papapanou, Panos N.; Rahman, Mahboob; Debanne, Sara M. (2008). "Clinical and Serologic Markers of Periodontal Infection and Chronic Kidney Disease." Journal of Periodontology 79(9): 1670-1678.
dc.identifier.issn0022-3492
dc.identifier.issn1943-3670
dc.identifier.urihttps://hdl.handle.net/2027.42/141492
dc.publisherAmerican Academy of Periodontology
dc.publisherWiley Periodicals, Inc.
dc.subject.otheredentulous
dc.subject.otherperiodontal diseases
dc.subject.otherrisk factors
dc.subject.otherAntibodies
dc.subject.otherjaws
dc.subject.otherkidney diseases
dc.titleClinical and Serologic Markers of Periodontal Infection and Chronic Kidney Disease
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelDentistry
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumDepartment of Cariology, Restorative Sciences, and Endodontics, School of Dentistry, University of Michigan, Ann Arbor, MI.
dc.contributor.affiliationotherDepartment of Orthodontics, School of Dental Medicine, Case Western Reserve University, Cleveland, OH.
dc.contributor.affiliationotherSection of Oral and Diagnostic Sciences, Division of Periodontics, College of Dental Medicine, Columbia University, New York, NY.
dc.contributor.affiliationotherDivision of Nephrology and Hypertension, School of Medicine, Case Western Reserve University.
dc.contributor.affiliationotherDepartment of Epidemiology and Biostatistics, School of Medicine, Case Western Reserve University.
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/141492/1/jper1670.pdf
dc.identifier.doi10.1902/jop.2008.070569
dc.identifier.sourceJournal of Periodontology
dc.identifier.citedreferenceOffenbacher S, Beck JD. A perspective on the potential cardioprotective benefits of periodontal therapy. Am Heart J 2005; 149: 950 – 954.
dc.identifier.citedreferenceBeck JD, Eke P, Heiss G, et al. Periodontal disease and coronary heart disease – A reappraisal of the exposure. Circulation 2005; 112: 19 – 24.
dc.identifier.citedreferenceBeck JD, Eke P, Lin D, et al. Associations between IgG antibody to oral organisms and carotid intima‐medial thickness in community‐dwelling adults. Atherosclerosis 2005; 183: 342 – 348.
dc.identifier.citedreferenceDye BA, Choudhary K, Shea S, Papapanou PN. Serum antibodies to periodontal pathogens and markers of systemic inflammation. J Clin Periodontol 2005; 32: 1189 – 1199.
dc.identifier.citedreferenceNational Center for Health Statistics. National Health and Nutrition Examination Survey III Documentation, Codebook, and Data Files. Available at: http://www.cdc.gov/nchs/about/major/nhanes/nh3data.htm. Accessed November 1, 2007.
dc.identifier.citedreferenceCoresh J, Astor BC, McQuillan G, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002; 39: 920 – 929.
dc.identifier.citedreferenceFisher MA, Taylor GW, Tilashalski KR. Smokeless tobacco and severe active periodontal disease, NHANES III. J Dent Res 2005; 84: 705 – 710.
dc.identifier.citedreferencePhipps KR, Stevens VJ. Relative contribution of caries and periodontal disease in adult tooth loss for an HMO dental population. J Public Health Dent 1995; 55: 250 – 252.
dc.identifier.citedreferenceDesvarieux M, Demmer RT, Rundek T, et al. Relationship between periodontal disease, tooth loss, and carotid artery plaque: The Oral Infections and Vascular Disease Epidemiology Study (INVEST). Stroke 2003; 34: 2120 – 2125.
dc.identifier.citedreferenceHujoel PP, Leroux BG, Selipsky H, White BA. Non‐surgical periodontal therapy and tooth loss. A cohort study. J Periodontol 2000; 71: 736 – 742.
dc.identifier.citedreferenceFrohlich ED, Grim C, Labarthe DR, Maxwell MH, Perloff A, Weidman WH. Recommendations for human blood pressure determination by sphygmomanometers. Hypertension 1988; 11: 209A – 222A.
dc.identifier.citedreferenceAmerican Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2007; 30 ( Suppl. 1 ): S42 – S47.
dc.identifier.citedreferencePussinen PJ, Tuomisto K, Jousilahti P, Havulinna AS, Sundvall J, Salomaa V. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol 2007; 27: 1433 – 1439.
dc.identifier.citedreferenceTonetti MS, D’Aiuto F, Nibali L, et al. Treatment of periodontitis and endothelial function. N Engl J Med 2007; 356: 911 – 920.
dc.identifier.citedreferenceRams TE, Listgarten MA, Slots J. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis subgingival presence, species‐specific serum immunoglobulin G antibody levels, and periodontitis disease recurrence. J Periodontal Res 2006; 41: 228 – 234.
dc.identifier.citedreferenceBeck JD, Offenbacher S. Systemic effects of periodontitis: Epidemiology of periodontal disease and cardiovascular disease. J Periodontol 2005; 76: 2089 – 2100.
dc.identifier.citedreferenceLoos BG. Systemic markers of inflammation in periodontitis. J Periodontol 2005; 76: 2106 – 2115.
dc.identifier.citedreferencePussinen PJ, Nyyssonen K, Alfthan G, Solonen R, Laukkanen JA, Salonen JT. Serum antibody levels to Actinobacillus actinomycetemcomitans predict the risk for coronary heart disease. Arterioscler Thromb Vasc Biol 2005; 25: 833 – 858.
dc.identifier.citedreferencePapapanou PN, Neiderud AM, Disick E, Lalla E, Miller GC, Dahlen G. Longitudinal stability of serum immunoglobulin G responses to periodontal bacteria. J Clin Periodontol 2004; 31: 985 – 990.
dc.identifier.citedreferenceCenters for Disease Control and Prevention (CDC). Prevalence of chronic kidney disease and associated risk factors – United States, 1999‐2004. MMWR Morb Mortal Wkly Rep 2007; 56: 161 – 165.
dc.identifier.citedreferenceBang H, Vupputuri S, Shoham DA, et al. SCreening for Occult REnal Disease (SCORED): A simple prediction model for chronic kidney disease. Arch Intern Med 2007; 167: 374 – 381.
dc.identifier.citedreferenceJamerson KA. Preventing chronic kidney disease in special populations. Am J Hypertens 2005; 18: 106S – 111S.
dc.identifier.citedreferenceTonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 2005; 68: 237 – 245.
dc.identifier.citedreferenceBasile DP. The endothelial cell in ischemic acute kidney injury: Implications for acute and chronic function. Kidney Int 2007; 72: 151 – 156.
dc.identifier.citedreferenceBeck JD, Caplan DJ, Preisser JS, Moss K. Reducing the bias of probing depth and attachment level estimates using random partial‐mouth recording. Community Dent Oral Epidemiol 2006; 34: 1 – 10.
dc.identifier.citedreferenceHennekens CH, Buring JE. Epidemiology in Medicine. Philadelphia: Lippincott Williams & Wilkins; 1987:35.
dc.identifier.citedreferenceGraswinckel JEM, van der Velden U, van Winkelhoff AJ, Hoek FJ, Loos BG. Plasma antibody levels in periodontitis patients and controls. J Clin Periodontol 2004; 31: 562 – 568.
dc.identifier.citedreferenceU.S. Department of Health and Human Services. The health benefits of smoking cessation: A report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, CDC; 1990.
dc.identifier.citedreferenceRahman M, Pressel S, Davis BR, et al. Renal outcomes in high‐risk hypertensive patients treated with an angiotensin‐converting enzyme inhibitor or a calcium channel blocker vs a diuretic. Arch Intern Med 2005; 165: 936 – 946.
dc.identifier.citedreferenceGo AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296 – 1305.
dc.identifier.citedreferenceCoresh J, Byrd‐Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005; 16: 180 – 188.
dc.identifier.citedreferenceNational Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (2 Suppl. 1): S1 – S266.
dc.identifier.citedreferenceCazzavillan S, Ratanarat R, Segala C, et al. Inflammation and subclinical infection in chronic kidney disease: A molecular approach. Blood Purif 2007; 25: 69 – 76.
dc.identifier.citedreferenceTonelli M, Pfeffer MA. Kidney disease and cardiovascular risk. Annu Rev Med 2007; 58: 123 – 139.
dc.identifier.citedreferenceStenvinkel P. New insights on inflammation in chronic kidney disease – genetic and non‐genetic factors. Nephrol Ther 2006; 2: 111 – 119.
dc.identifier.citedreferenceLevey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137 – 147.
dc.identifier.citedreferenceKshirsagar AV, Offenbacher S, Moss KL, Barros SP, Beck JD. Antibodies to periodontal organisms are associated with decreased kidney function. The Dental Artherosclerosis Risk in Communities Study. Blood Purif 2007; 25: 125 – 132.
dc.identifier.citedreferenceFisher MA, Taylor GW, Shelton BJ, et al. Periodontal disease and other non‐traditional risk factors for CKD. Am J Kidney Dis 2008; 51: 45 – 52.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jper1670.pdf
Size:
476.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.